- In April 2025, Globus Medical announced the completion of its acquisition of Nevro Corp., aiming to accelerate market penetration of Nevro's high-frequency technology for chronic pain. Nevro's HFX spinal cord stimulation (SCS) platform includes the Senza SCS system. This acquisition expands Globus Medical's presence in the musculoskeletal market
- In November 2024, Nevro's HFX iQ Spinal Cord Stimulation with AI Technology received CE Mark Certification in Europe. HFX iQ is described as the first and only SCS system integrating high-frequency SCS with cloud data insights for personalized, data-driven patient care, leveraging an algorithm built from over 20 million data points
- In January 2025, Medtronic announced 12-month clinical data highlighting significant and sustained benefits of its Inceptiv closed-loop spinal cord stimulation (CL-SCS) system for patients with chronic low back and leg pain. The Inceptiv system received FDA approval in April 2024 and senses biological signals to automatically adjust stimulation in real-time
- In April 2025, Abbott launched its next-generation delivery system to streamline the implantation process for electrodes used as part of its Proclaim dorsal root ganglion (DRG) neurostimulation system. This system is designed to improve the procedure for patients suffering from complex regional pain syndrome (CRPS) of the lower extremities
- In June 2022, Stimwave Technologies Incorporated and Stimwave LLC filed for bankruptcy protection under Chapter 11. Certain assets were subsequently purchased by Curonix LLC. Patients with Stimwave devices are advised to contact their physicians for ongoing support
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Rechargeable Spinal Cord Stimulator Systems, and Non-Rechargeable Spinal Cord Stimulator Systems), Application (Sciatica and FBS (Failed Back Syndrome), Arachnoiditis, Degenerative Disk Disease, and Others) - Industry Trends and Forecast to 2032
.
The Global Spinal Cord Stimulators Market size was valued at USD 2.64 USD Billion in 2024.
The Global Spinal Cord Stimulators Market is projected to grow at a CAGR of 8.1% during the forecast period of 2025 to 2032.
The major players operating in the market include Nevro Corp. , St. Jude Childrens Research Hospital , Synapse Biomedical Inc , NeuroSigma Inc U.S), Medtronic , Greatbatch , NDI Medical LLC , NeuroPace Inc. , Abbott , Autonomic Technologies Inc Germany), Beijing PINS Medical Co.Ltd, Cirtec Medical Corporation , Boston Scientific Corporation , Stimwave LLC , Saluda Medical Pty Ltd. .
The market report covers data from the North America.
